If not now, when? Prescription of evidence-based medical therapy prior to hospital discharge increases utilization at 6 months in patients with symptomatic peripheral artery disease

In conclusion, prescription of the component medications of EBMT at the time of PVI is associated with excellent utilization at 6 months, while failure to prescribe EBMT at discharge is associated with low use of these medications 6 months later. These data suggest that the time of a PVI is a therapeutic window in which to prescribe EBMT in this high-risk cohort and represents an opportunity for quality improvement.

Source: Vascular Medicine - November 23, 2015 Category: Internal Medicine Authors: Renard, B. M., Seth, M., Share, D., Aronow, H. D., Laveroni, E. W., De Gregorio, M., Hans, S. S., Henke, P. K., Gurm, H. S., Grossman, P. M. Tags: Original Articles Source Type: research